FavId Shows Promise
for relapsed NHL patients (The Pharm Voice)
In her blog, Gloria Gamat
discusses Favrille's recently announced results of a Phase II trial of its non-Hodgkin's
lymphoma (NHL) drug FavId.
FavId Shows Promise
for relapsed NHL patients (The Pharm Voice)
In her blog, Gloria Gamat
discusses Favrille's recently announced results of a Phase II trial of its non-Hodgkin's
lymphoma (NHL) drug FavId.
Copyright ©2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing